WallStreetZenWallStreetZen

NASDAQ: ALT
Altimmune Inc Earnings & Revenue

Open Broker Account

ALT past revenue growth

How has ALT's revenue growth performed historically?
Company
-3.66%
Industry
118.29%
Market
187.28%
ALT's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
ALT's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
ALT's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

ALT earnings and revenue history

Current Revenue
$3.3M
Current Earnings
-$86.9M
Current Profit Margin
-2,619%

ALT Return on Equity

Current Company
-44.4%
Current Industry
-9.8%
Current Market
-8.3%
ALT's Return on Equity (-44.4%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when ALT announces earnings.

ALT Return on Assets

Current Company
-40.5%
Current Industry
0.7%
ALT is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

ALT Return on Capital Employed

Current Company
-41.53%
Current Industry
11.5%
ALT has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

ALT vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
ALT$3.32M-$86.86M-$86.94M-18.11%N/A
CINC$0.00-$88.09M-$88.09MN/AN/A
ESPR$72.06M-$186.82M-$243.29M-79.95%N/A
CGEM$0.00$149.51M$105.48M-100.00%N/A
MLTX$0.00-$99.32M-$99.36MN/AN/A

Altimmune Earnings & Revenue FAQ

What were ALT's earnings last quarter?

On Invalid Date, Altimmune (NASDAQ: ALT) reported Q3 2022 earnings per share (EPS) of -$0.48, up 40.74% year over year. Total Altimmune earnings for the quarter were -$23.52 million. In the same quarter last year, Altimmune's earnings per share (EPS) was -$0.81.

If you're new to stock investing, here's how to buy Altimmune stock.

What was ALT's earnings growth in the past year?

As of Q4 2022, Altimmune's earnings has grown year over year. Altimmune's earnings in the past year totalled -$86.94 million.

What was ALT's revenue last quarter?

On Invalid Date, Altimmune (NASDAQ: ALT) reported Q3 2022 revenue of $2.00 thousand up 98.73% year over year. In the same quarter last year, Altimmune's revenue was $158.00 thousand.

What was ALT's revenue growth in the past year?

As of Q4 2022, Altimmune's revenue has grown -3.66% year over year. This is 121.94 percentage points lower than the US Biotechnology industry revenue growth rate of 118.29%. Altimmune's revenue in the past year totalled $3.32 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.